아시아인의 일측성 성대마비 치료에서 Calcium Hydroxyapatite의 효과
Efficacy of Calcium Hydroxyapatite in Vocal Fold Augmentation for Unilateral Vocal Fold Paralysis in Asian
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background and Objectives：This study aimed to evaluate efficacy and complication of injection laryngoplasty using calcium hydroxyapatite (CaHA) for unilateral vocal fold paralysis in Asian. Materials and Methods：A prospective study was conducted on the adult patients with unilateral vocal fold paralysis from May 2015 through January 2016. Injection laryngoplasty was performed by one laryngologist. All patients underwent prospective voice evaluation using the subjective and objective comprehensive battery of assessments, before the procedure and after the procedure at 3 months, and 6 months. Results：A total of 7 patients (5 males and 2 females) were included in this study. VHI-10 was significantly decreased after injection laryngoplasty, at postoperative 6 months (p=0.031), while VAS score and MDADI showed no difference. GRBAS scale gradually decreased in 3 months and 6 months follow-up without statistical significance. Acoustic analysis revealed that jitter, shimmer, and noise-to-harmonic ratio continuously decreased from the baseline at 3 months and 6 months, although statistical significance was not attained. In the aerodynamic analysis, maximal phonation time was gradually increased at 3months and 6 months with significant difference (p=0.016, 0.031, respectively). There was no side effect associated with the procedure. Conclusion：CaHA can be safely used in Asian patients and the onset of maximal efficacy seems to be slow than other studies with Caucasian patients.
Abstract
Background and Objectives：This study aimed to evaluate efficacy and complication of injection laryngoplasty using calcium hydroxyapatite (CaHA) for unilateral vocal fold paralysis in Asian. Materials and Methods：A prospective study was conducted on the adult patients with unilateral vocal fold paralysis from May 2015 through January 2016. Injection laryngoplasty was performed by one laryngologist. All patients underwent prospective voice evaluation using the subjective and objective comprehensive battery of assessments, before the procedure and after the procedure at 3 months, and 6 months. Results：A total of 7 patients (5 males and 2 females) were included in this study. VHI-10 was significantly decreased after injection laryngoplasty, at postoperative 6 months (p=0.031), while VAS score and MDADI showed no difference. GRBAS scale gradually decreased in 3 months and 6 months follow-up without statistical significance. Acoustic analysis revealed that jitter, shimmer, and noise-to-harmonic ratio continuously decreased from the baseline at 3 months and 6 months, although statistical significance was not attained. In the aerodynamic analysis, maximal phonation time was gradually increased at 3months and 6 months with significant difference (p=0.016, 0.031, respectively). There was no side effect associated with the procedure. Conclusion：CaHA can be safely used in Asian patients and the onset of maximal efficacy seems to be slow than other studies with Caucasian patients.
참고문헌 (18)
- Rosen CA, "Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results", J Voice, 18, pp.387~391 (2004)
- Belafsky PC, "Vocal fold augmentation with calcium hydroxylapatite", Otolaryngol Head Neck Surg, 131, pp.351~354 (2004)
- Chhetri DK, "Injection laryngoplasty with calcium hydroxylapatite gel implant in an in vivo canine model", Ann Otol Rhinol Laryngol, 113, pp.259~264 (2004)
- Caton T, "Viscoelasticity of hyaluronan and nonhyaluronan based vocal fold injectables: implications for mucosal versus muscle use", Laryngoscope, 117, pp.516~521 (2007)
- DeFatta RA, "Complications of injection laryngoplasty using calcium hydroxylapatite", J Voice, 26, pp.614~618 (2012)
- 원성준, "Calcium Hydroxylapatite Pulmonary Embolism after Percutaneous Injection Laryngoplasty", Yonsei Medical Journal, 58(6), pp.1245~1248 (2017), 연세대학교의과대학[DOI]
- Rosen CA, "Development and validation of the voice handicap index-10", Laryngoscope, 114, pp.1549~1556 (2004)
- 권찬혁, "Validity and Reliability of the Korean Version of the MD Anderson Dysphagia Inventory for Head and Neck Cancer Patients", Annals of Rehabilitation Medicine, 37(4), pp.479~487 (2013), 대한재활의학회
- Rosen CA, "Vocal fold augmentation with calcium hydroxylapatite:twelve-month report", Laryngoscope, 119, pp.1033~1041 (2009)
- Carroll TL, "Long-term results of calcium hydroxylapatite for vocal fold augmentation", Laryngoscope, 121, pp.313~319 (2011)
- Ford CN, "Role of injectable collagen in the treatment of glottic insufficiency: a study of 119 patients", Ann Otol Rhinol Laryngol, 101, pp.237~247 (1992)
- Laccourreye O, "Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient’s perspective", Laryngoscope, 113, pp.541~545 (2003)
- Karpenko AN, "Cymetra injection for unilateral vocal fold paralysis", Ann Otol Rhinol Laryngol, 112, pp.927~934 (2003)
- Nakayama M, "Teflon vocal fold augmentation:failures and management in 28 cases", Otolaryngol Head Neck Surg, 109, pp.493~498 (1993)
- Rubin HJ, "Pitfalls in Treatment Od Dysphonias by Intracordal Injection of Synthetics", Laryngoscope, 75, pp.1381~ (1965)
- Woo SH, "Comparative Analysis on the Efficiency of the Injection Laryngoplasty Technique Using Calcium Hydroxyapatite (CaHA): The Thyrohyoid Approach Versus the Cricothyroid Approach", Journal of Voice, 27, pp.236~241 (2013)
- Kwon TK, "Serial computed tomographic and positron emission tomographic properties of injection material used for vocal fold augmentation", Laryngoscope, 123(10), pp.2491~2496 (2013)
- Chhetri DK, "Injection laryngoplasty with calcium hydroxylapatite gel implant in an in vivo canine model", Ann Oto Rhinol Laryn, 113, pp.259~264 (2004)